|Bid||0.00 x 900|
|Ask||309.90 x 1100|
|Day's Range||294.09 - 302.04|
|52 Week Range||119.01 - 319.19|
|Beta (5Y Monthly)||0.99|
|PE Ratio (TTM)||84.90|
|Earnings Date||Oct 29, 2020 - Nov 02, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||326.40|
ABIOMED's (ABMD) flagship Impella saw decline in revenues internationally and within the United States, in Q1.
Abiomed (ABMD) delivered earnings and revenue surprises of 176.19% and 19.26%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Abiomed announces Q1 FY 2021 revenue of $165 million and 21% operating margin.